Dubai London Hospital launches its hospital with the most modern technology and community-centric healthcare services

Dubai London Hospital, a bespoke community hospital set to redefine personalised, premium, and patient-centric healthcare, has officially opened its doors at Jumeirah Beach Road on March 29, 2022. The momentous ribbon-cutting ceremony was graced by His Highness Sheikh Saeed bin Mohammed bin Hasher Al Maktoum, and was led by Dubai London Hospital Group’s Founder and Managing Partner, Dr. Misho Ravic, and Executive Director, Mr. Bharat Ratteshwar. As part of the Dubai London Clinic & Speciality Hospital that has been widely respected as a reliable healthcare provider with a presence in the country for over 34 years, Dubai London Hospital is … Continue reading Dubai London Hospital launches its hospital with the most modern technology and community-centric healthcare services

Arab Health 2022 & Medlab : Interview with Roy Tan, General Manager of MGI Asia Pacific

  Roy Tan, General Manager of MGI Asia Pacific Can you please tell us a bit about MGI and what the company specializes in? MGI (MGI Tech Co. Ltd.) is a company that builds tools and technology to lead life science through intelligent innovation. Building on our own technological inventions, we focus on the research & development, production and sales of innovative sequencing instruments*, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. Founded in 2016 and headquartered in Shenzhen, China, we are now the global leader in the gene sequencing industry. As a leading … Continue reading Arab Health 2022 & Medlab : Interview with Roy Tan, General Manager of MGI Asia Pacific

Philip Morris International Applauds U.K. Government’s Approach to Achieve its Smoke-Free Ambition

Calls on regulators internationally to follow the example of the U.K. and lessen the impact of income inequality on access to better alternatives than continued smoking Philip Morris International Inc. (PMI) (NYSE: PM) announced its support of the U.K. government’s plan to simplify the pathway to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in England. The U.K. already has one of Europe’s lowest smoking rates, supported by a high rate of smokers who have switched to better alternatives. This proposal makes the U.K. the first country in the world to encourage the medical licensing of e-cigarettes via prescription as a route to further lower … Continue reading Philip Morris International Applauds U.K. Government’s Approach to Achieve its Smoke-Free Ambition

COVID-19 Treatment, Codivir, proves fastest and most effective in Phase 1 clinical trials – patients recovering with no side effects within 48 hours

Trials saw COVID-19 affected patients recovering with no side effects in 48 hours From the start of the pandemic, researchers, scientists, and antivirus specialists have worked around the clock to find a way to treat COVID-19. Codivir, an innovative new drug from Code Pharma, now appears to have the potential to revolutionize the fight against the virus. In a successful phase 1 clinical trial, the affected patients were back on their feet within 48 hours without side effects. Zyon Ayni, Founder and CEO of Code Pharma, “Codivir showed great success in clinical trials and already has received emergency approvals in … Continue reading COVID-19 Treatment, Codivir, proves fastest and most effective in Phase 1 clinical trials – patients recovering with no side effects within 48 hours